David Kessler likely to retire from the FDA:
This article was originally published in Clinica
Executive Summary
After six years as commissioner of the US FDA, The Washington Times reports that David Kessler intends to join the exodus of top-level officials from President Clinton's administration. Dr Kessler has been assiduous in efforts to have nicotine classified as a drug and thus made subject to regulation. He has also led attempts to speed the agency's approvals processes for drugs and devices. Dr Kessler's spokesman told Clinica that the commissioner's departure was not imminent, but that Dr Kessler had accomplished all his long term goals for the agency.